MASSDEVICE ON CALL — Attendees at the IBF MedTEch Investing Conference in Minneapolis weren’t put off by predictions that only 10 U.S. startups seeking PMA’s from the Food & Drug Administration will win venture capital backing this year.
Despite a highly competitive and seemingly dire market, startups can still finding funding.
Startups should consider strategic deals with angel and super angel investors, strategic partnerships with corporate acquirers and early stage funds from public money, conference attendees said.